Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LOC100420226 (ENSG00000227948) encodes a pseudogene similar to part of argininosuccinate synthetase 1 (ASS1), but it does not encode a functional protein and does not have a direct biological function or disease association. Pseudogenes are genomic DNA sequences similar to normal genes but generally nonfunctional; they do not code for functional proteins or RNAs. Thus, LOC100420226 is not considered a therapeutic target or a molecule involved in any established pathway or disease mechanism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Argininosuccinate synthase 1 pseudogene.